At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 35 enrolled
Drug / intervention
Vitamin D3 +2 moredrug
Likely dose
Vitamin D3 4000 IUfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Addition of Vitamin D to Fluticasone Propionate in the Management of Seasonal Allergic Rhinitis
In Brief
A Phase 4 clinical trial evaluating Vitamin D3, Placebo, and 1 other intervention for Seasonal Allergic Rhinitis. Completed, enrolled 35 participants across 1 site.
Detailed Summary
The objectives of this study would be to see if the addition of vitamin D to fluticasone propionate provides greater symptomatic relief in patients with seasonal allergic rhinitis compared to fluticasone propionate treatment alone.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSeasonal Allergic Rhinitis
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedApr 2010
Enrollment StartJun 2010
Primary CompletionJul 2011
TodayJul 2026
First PostedApr 15, 2010
Enrollment StartJun 1, 2010
Primary CompletionJul 1, 2011
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 16.2 years ago
Interventions
Vitamin D3drug
4000 IU once daily
Placebodrug
Placebo taken once daily
Fluticasone Propionatedrug
200 mcg daily, intranasal